First compulsory licence application in India
Indian generic drug maker Natco has filed a compulsory licence application for the patent covering German pharma company Bayer’s anti-cancer drug Nexavar
This is the first application for a compulsory licence in India and, if successful, could pave the way for a series of claims from other generic companies.
"On the merits, they have a decent case," said Shamnad Basheer, a professor...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.